Clinical Trial Update: A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of atorvastatin for lowering cholesterol in Latin American patients with dyslipidemias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Dyslipidemias | Phase 4 | Status: COMPLETED